Bicycle Therapeutics Plc (BCYC)
4.34
-0.03
(-0.69%)
USD |
NASDAQ |
Aug 24, 16:00
4.42
+0.08
(+1.84%)
After-Hours: 20:00
Bicycle Therapeutics Shareholders Equity (Quarterly) : 510.26M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 510.26M |
| March 31, 2026 | 554.32M |
| December 31, 2025 | 609.98M |
| September 30, 2025 | 618.48M |
| June 30, 2025 | 668.92M |
| March 31, 2025 | 740.33M |
| December 31, 2024 | 793.06M |
| September 30, 2024 | 831.03M |
| June 30, 2024 | 873.81M |
| March 31, 2024 | 356.05M |
| December 31, 2023 | 370.93M |
| September 30, 2023 | 416.02M |
| June 30, 2023 | 220.10M |
| March 31, 2023 | 243.16M |
| December 31, 2022 | 270.78M |
| September 30, 2022 | 289.47M |
| June 30, 2022 | 311.39M |
| March 31, 2022 | 330.26M |
| Date | Value |
|---|---|
| December 31, 2021 | 346.25M |
| September 30, 2021 | 170.82M |
| June 30, 2021 | 142.05M |
| March 31, 2021 | 142.09M |
| December 31, 2020 | 95.46M |
| September 30, 2020 | 109.55M |
| June 30, 2020 | 71.03M |
| March 31, 2020 | 81.81M |
| December 31, 2019 | 93.20M |
| September 30, 2019 | 95.32M |
| June 30, 2019 | 104.56M |
| March 31, 2019 | 48.81M |
| December 31, 2018 | 52.37M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 43.10M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Autolus Therapeutics Plc | 74.84M |
| Akari Therapeutics Plc | 18.60M |
| Biodexa Pharmaceuticals Plc | -- |
| DBV Technologies SA | -- |
| Cellectis SA | 41.07M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 606.58M |
| Total Liabilities (Quarterly) | 96.32M |
| Debt to Equity Ratio | 0.0298 |
| Current Ratio | 12.08 |
| Net Debt Paydown Yield | -0.57% |